ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,051.25
-0.54%
US Tech 100
21,060.00
0.00%
Dow Jones
43,914.12
-0.53%
Brent Oil
73.41
0.27%
Bitcoin
100,050.21
-0.01%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) News

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRWD
DateTimeSourceHeadlineSymbolCompany
12/05/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/26/20244:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/20/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/20/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/15/20244:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/15/20244:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/14/20243:31PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/13/20244:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20245:22PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/07/20247:00AMBusiness WireIronwood Pharmaceuticals Reports Third Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/28/20247:00AMBusiness WireOnce-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
10/24/20244:00PMBusiness WireIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/23/20245:04PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/30/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/29/20244:01PMBusiness WireIronwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/14/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/14/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/09/20244:05PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/20247:00AMBusiness WireIronwood Pharmaceuticals Reports Second Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/25/20244:00PMBusiness WireIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/10/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/10/20244:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/07/20241:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/06/20243:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
05/30/20244:01PMBusiness WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD

Your Recent History

USOTC
AXXA
Exxe (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
AZRH
Azure (PK)
USOTC
PHIL
PHI (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
USOTC
GTCH
GBT Technologies (PK)
USOTC
ZHUD
Zhuding (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
UATG
Umbra Applied Technologies (PK)
USOTC
BCAP
Baron Capital Enterprise (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
ILLR
Triller
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved